MedPath
FDA Approval

Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

February 8, 2024

HUMAN PRESCRIPTION DRUG LABEL

Butalbital(50 mg in 1 1)
Caffeine(40 mg in 1 1)
Acetaminophen(325 mg in 1 1)
Codeine(30 mg in 1 1)

Manufacturing Establishments (1)

LGM Pharma Solutions, LLC

Breckenridge Pharmaceutical, Inc.

117549200

Products (1)

Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

51991-073

ANDA076560

ANDA (C73584)

ORAL

October 31, 2023

Code: KHS0AZ4JVKClass: ACTIBQuantity: 50 mg in 1 1
CaffeineActive
Code: 3G6A5W338EClass: ACTIBQuantity: 40 mg in 1 1
FD&C Red No. 3Inactive
Code: PN2ZH5LOQYClass: IACT
FD&C Yellow No. 5Inactive
Code: I753WB2F1MClass: IACT
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327LClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
Sodium Lauryl SulfateInactive
Code: 368GB5141JClass: IACT
Titanium DioxideInactive
Code: 15FIX9V2JPClass: IACT
TalcInactive
Code: 7SEV7J4R1UClass: IACT
Code: 362O9ITL9DClass: ACTIBQuantity: 325 mg in 1 1
CodeineActive
Code: GSL05Y1MN6Class: ACTIBQuantity: 30 mg in 1 1
FD&C Blue No. 1Inactive
Code: H3R47K3TBDClass: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOAClass: IACT
Stearic AcidInactive
Code: 4ELV7Z65APClass: IACT

Drug Labeling Information

RECENT MAJOR CHANGES SECTION

RECENT MAJOR CHANGES

Dosage and Administration (2.2)

03/2021

Warnings and Precautions (5.1, 5.3, 5.4)

03/2021


DOSAGE FORMS & STRENGTHS SECTION

Highlight: * Capsules: 50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine, and 30 mg codeine phosphate.

3 DOSAGE FORMS AND STRENGTHS

Capsules: Butalbital 50 mg, Acetaminophen 325 mg, Caffeine 40 mg, Codeine Phosphate 30 mg

Blue, opaque cap with a gray, opaque body, and body is imprinted with "B073" in black ink.


CONTRAINDICATIONS SECTION

Highlight: * Children younger than 12 years of age. (4)

  • Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy. (4)
  • Significant respiratory depression. (4)
  • Acute or severe bronchial asthma in an unmonitored setting or in absence of resuscitative equipment. (4)
  • Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days. (4)
  • Known or suspected gastrointestinal obstruction, including paralytic ileus. (4)
  • Intolerance or hypersensitivity to acetaminophen, caffeine, butalbital or codeine, or components of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. (4)
  • Porphyria. (4)

4 CONTRAINDICATIONS

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are contraindicated for:

  • All children younger than 12 years of age [see Warnings and Precautions (5.5)].
  • Post-operative management in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [see Warnings and Precautions (5.5)].

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are also contraindicated in patients with:

  • Significant respiratory depression [see Warnings and Precautions (5.3)]
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see Warnings and Precautions (5.9)]
  • Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days [see Warnings and Precautions (5.10), Drug Interactions (7)]
  • Known or suspected gastrointestinal obstruction, including paralytic ileus [see Warnings and Precautions (5.14)]
  • Known intolerance or hypersensitivity to acetaminophen, caffeine, butalbital, or codeine or to the components of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules
  • Porphyria

BOXED WARNING SECTION

**WARNING: ADDICTION, ABUSE, AND MISUSE; RISK EVALUATION AND MITIGATION

STRATEGY (REMS); LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS; ULTRA-RAPID METABOLISM OF CODEINE AND OTHER RISK FACTORS FOR LIFE-THREATENING RESPIRATORY DEPRESSION IN CHILDREN; NEONATAL OPIOID WITHDRAWAL SYNDROME; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; and HEPATOTOXICITY**


SPL MEDGUIDE SECTION

Medication Guide

Dispense with Medication Guide available at: www.bpirx.com/products/patientinformation

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, C III

Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules are:

  • A strong prescription pain medicine that contains an opioid (narcotic) that is indicated for the relief of the symptom complex of tension (or muscle contraction) headache, when other pain treatments such as non-opioid pain medicines do not treat your pain well enough or you cannot tolerate them.
  • An opioid pain medicine that can put you at risk for overdose and death. Even if you take your dose correctly as prescribed you are at risk for opioid addiction, abuse, and misuse that can lead to death.

Important information about Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules:

*Get emergency help or call 911 right away if you take too much Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules (overdose). When you first start taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, when your dose is changed, or if you take too much (overdose), serious or life-threatening breathing problems that can lead to death may occur. Talk to your healthcare provider about naloxone, a medicine for the emergency treatment of an opioid overdose.

  • Taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, breathing problems, coma, and death.
  • Never give anyone else your Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. They could die from taking it. Selling or giving away Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules is against the law.
  • Store Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules securely, out of sight and reach of children, and in a location not accessible by others, including visitors to the home.
  • Get emergency help right away if you take more than 4,000 mg of acetaminophen in 1 day. Taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with other products that contain acetaminophen can lead to serious liver problems and death.

Important Information Guiding Use in Pediatric Patients:

  • Do not give Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules to a child younger than 12 years of age.
  • Do not give Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules to a child younger than 18 years of age after surgery to remove the tonsils and/or adenoids.
  • Avoid giving Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules to children between 12 to 18 years of age who have risk factors for breathing problems such as obstructive sleep apnea, obesity, or underlying lung problems.

Do not take Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules if you have:

  • severe asthma, trouble breathing, or other lung problems.
  • a bowel blockage or have narrowing of the stomach or intestines.

Before taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, tell your healthcare provider if you have a history of:

  • head injury, seizures
  • problems urinating
  • abuse of street or prescription drugs, alcohol addiction, opioid overdose, or mental health problems.
  • Have been told by your healthcare provider that you are a "rapid metabolizer" of certain medicines
  • liver, kidney, thyroid problems
  • pancreas or gallbladder problems

Tell your healthcare provider if you are:

*pregnant or planning to become pregnant. Prolonged use of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, during pregnancy can cause withdrawal symptoms in your newborn baby that could be life-threatening if not recognized and treated. *breastfeeding. Not recommended; may harm your baby.

  • living in a household where there are small children or someone who has abused street or prescription drugs.
  • taking prescription or over-the-counter medicines, vitamins, or herbal supplements. Taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules with certain other medicines can cause serious side effects that could lead to death.

When taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules:

  • Do not change your dose. Take Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules exactly as prescribed by your healthcare provider. Use the lowest dose possible for the shortest time needed.
  • Take your prescribed dose of 1 or 2 capsules every 4 hours. Total daily dosage should not exceed 6 capsules. Do not take more than your prescribed dose. If you miss a dose, take your next dose at your usual time.
  • Call your healthcare provider if the dose you are taking does not control your pain.
  • If you have been taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules regularly, do not stop taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules without talking to your healthcare provider.
  • After you stop taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, dispose the unused Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules in accordance with the local state guidelines and/or regulations.
  • Dispose of expired, unwanted, or unused Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules by taking your drug to an authorized DEA-registered collector or drug take-back program. If one is not available, you can dispose of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules by mixing the product with dirt, cat litter, or coffee grounds; placing the mixture in a sealed plastic bag, and throwing the bag in your trash.

While taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules DO NOT:

  • Drive or operate heavy machinery, until you know how Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules affect you. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules can make you sleepy, dizzy, or lightheaded.
  • Drink alcohol or use prescription or over-the-counter medicines that contain alcohol. Using products containing alcohol during treatment with Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules may cause you to overdose and die.

The possible side effects of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules:

  • constipation, nausea, sleepiness, vomiting, tiredness, headache, dizziness, abdominal pain. Call your healthcare provider if you have any of these symptoms and they are severe.

Get emergency medical help or call 911 right away if you:

  • have trouble breathing, shortness of breath, fast heartbeat, chest pain, swelling of your face, tongue, or throat, extreme drowsiness, light-headedness when changing positions, feeling faint, agitation, high body temperature, trouble walking, stiff muscles, or mental changes such as confusion.
  • are a nursing mother taking Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules, and your breastfeeding baby has increased sleepiness, confusion, difficulty breathing, shallow breathing, limpness, or difficulty breastfeeding.

These are not all the possible side effects of Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov
Manufactured by:
LGM Pharma Solutions, LLC,
Irvine, CA 92614
Manufactured for:
Breckenridge Pharmaceutical, Inc.,
Berkeley Heights, NJ 07922

This Medication Guide has been approved by the U.S. Food and Drug Administration.

6670

Rev. 10/2023


SPL UNCLASSIFIED SECTION

Dispense with Medication Guide available at: www.bpirx.com/products/patientinformation

Manufactured by:
LGM Pharma Solutions, LLC
Irvine, CA 92614

Manufactured for:
Breckenridge Pharmaceutical, Inc.
Berkeley Heights, NJ 07922

6670

Rev. 10/2023


© Copyright 2025. All Rights Reserved by MedPath